Super Bowl LIX festivities are in full swing in New Orleans ahead of the big game on Feb. 9. Why it matters: Follow us this ...

There is nothing like dozens of couples saying “I do” simultaneously to warm the frigid air that grips the Colorado Rockies in the heart of winter.

Devices designed for convenience and patient comfort in visual field tests, stainless steel frames and sunglasses inspired by ...

Why you should consider this: Whether it's a crowded office or a crowded commute, noise-cancelling headphones give that ...

When it comes to Anne Hathaway (or Annie as V has come to know her), it’s no secret that one of America’s sweethearts is ...

A high-end multi-functional appliance that aims to replace your oven, microwave and air fryer – but does it live up to its ...

In a report released today, Joon Lee from Truist Financial maintained a Hold rating on SAGE Therapeutics (SAGE – Research Report). The company’s shares closed yesterday at $7.16. Leverage the ...

Scotiabank analyst George Farmer maintained a Buy rating on SAGE Therapeutics (SAGE – Research Report) today and set a price target of $12.00. The company’s shares closed yesterday at $7.19.

The Sun Ra Arkestra leader is releasing his first solo album at age 100. Plus, Questlove's 'Sly Lives,' and funk, soul- ...

Jan 27 (Reuters) - Sage Therapeutics (SAGE.O), opens new tab said on Monday that its board has unanimously rejected Biogen’s (BIIB.O), opens new tab $469 million offer, stating it "significantly ...